Absorption

The Chemours Company Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, March 27, 2024
Technology, Construction & Property, Semiconductor, Automotive, Engineering, Chemicals, Plastics, Other Automotive, Manufacturing, Machine Tools, Metalworking & Metallurgy, Other Construction & Property, Immersion, EUR, Corteva, Advanced Materials, Absorption, Growth, PFAS, Segment, TSS, Intermediate 1, Form, District court, Webcast, Capital expenditure, Electronics, Accounting, Public expenditure, Capital, Judgement, Adjustment, APM, Event, USD, Titanium dioxide, Drinking water, Corporation, Fine chemical

APM segment fourth quarter 2023 Net Sales were $325 million, down 15% compared to the fourth quarter 2022.

Key Points: 
  • APM segment fourth quarter 2023 Net Sales were $325 million, down 15% compared to the fourth quarter 2022.
  • Performance Solutions portfolio’s fourth quarter 2023 Net Sales were $134 million, up 11% vs. the prior-year quarter.
  • Advanced Materials portfolio’s fourth quarter 2023 Net Sales were $191 million, down 27% vs. the prior-year quarter.
  • For the first quarter 2024, we expect consolidated Net Sales to be flat to slightly down sequentially, with consolidated Adjusted EBITDA down approximately 10% compared with fourth quarter 2023 results.

Ampco-Pittsburgh Corporation (NYSE: AP) Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 25, 2024
Engineering, Machine Tools, Metalworking & Metallurgy, Manufacturing, Steel, FEP, AP, Absorption, Asbestos, Corporation, Internet, Policy, Insurance, Ampco Pittsburgh, Credit, Interest, Cryptocurrency

Both the Asbestos-Related Charge and the Asbestos-Related Credit are recorded in the Air and Liquid Processing segment’s operating results for the applicable periods.

Key Points: 
  • Both the Asbestos-Related Charge and the Asbestos-Related Credit are recorded in the Air and Liquid Processing segment’s operating results for the applicable periods.
  • Segment operating results for the three months ended December 31, 2023, improved compared to the prior year primarily due to higher shipment volumes.
  • Ampco-Pittsburgh Corporation will hold a conference call on March 26, 2024, at 10:30 a.m. Eastern Time (ET) to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • The Corporation encourages participants to pre-register at any time, including up to and after the call start time via this link: https://dpregister.com/sreg/10186688/fbaa9e10c0 .

Azuca Takes the Fast Lane with Infusions in the Hemp Cannabinoid Market Through Strategic Collaboration with Open Book Extracts

Retrieved on: 
Thursday, April 4, 2024
RTD, Absorption, CGMP, Inhalation, Titan Mare Explorer, Infusion, OBX, NSF, Drink, B2B, Chocolate, THC

NEW YORK, April 4, 2024 /PRNewswire/ -- Azuca, a trailblazer in advanced infusions within the regulated cannabis market, today announced a strategic collaboration with leading cannabinoid ingredient and product manufacturer Open Book Extracts (OBX) for the burgeoning hemp market, inclusive of federally-compliant, hemp-derived delta-9 THC.

Key Points: 
  • This collaboration harnesses Azuca's innovative TiME INFUSION® process and ACTiVATOR® product line with OBX's expertise in cannabinoid ingredients, product development, and finished goods manufacturing.
  • Positioned as a "fast track" solution, Azuca and OBX will offer brands and manufacturers a streamlined pathway from concept to market, significantly reducing the time it takes to reach consumers.
  • "At Azuca, we are dedicated to pushing the boundaries of innovation to deliver efficient, reliable, and delicious cannabis experiences for consumers.
  • "Open Book Extracts is committed to making products that work for brands that care," shares Nicole Brown, OBX Chief Innovation Officer.

United States Patent and Trademark Office Grants Patents to PittMoss for Groundbreaking Peat Moss Substitute and Related Production Processes

Retrieved on: 
Thursday, April 4, 2024
Pesticide, Absorption, PFAS, Environment, Patent, Gardening, Carbon, Biodiversity, Horticulture, Plant, Soil, IP, CO2, Water, Paper, Herbicide

PITTSBURGH , April 4, 2024 /PRNewswire/ -- PittMoss, a leading innovator in sustainable gardening solutions, today announces the United States Patent and Trademark Office (USPTO) has granted the company two patents for its revolutionary materials designed as substitutes for peat moss, along with the processes and apparatuses used for the production of the products.

Key Points: 
  • PITTSBURGH , April 4, 2024 /PRNewswire/ -- PittMoss, a leading innovator in sustainable gardening solutions, today announces the United States Patent and Trademark Office (USPTO) has granted the company two patents for its revolutionary materials designed as substitutes for peat moss, along with the processes and apparatuses used for the production of the products.
  • Specifically, the patented processes developed by PittMoss enable the production of bulk materials with physical properties similar to peat moss, making them ideal for various applications within the gardening and agricultural sectors.
  • Readily Available Nutrition: The unique structure of PittMoss materials allows for efficient absorption and release of organic nutrients, ensuring optimal distribution and utilization.
  • By reducing reliance on peat moss, which is a non-renewable resource harvested from sensitive ecosystems, PittMoss contributes to biodiversity conservation and carbon sequestration efforts.

Flash News: OKX Wallet Now Integrated with Arkreen

Retrieved on: 
Wednesday, April 3, 2024
Refinancing, OKX, Partnership, Web3, Firefox, Absorption, Chrome, Nifedipine, Cryptocurrency

OKX Wallet is thrilled to announce its integration with Arkreen , a revolutionary Web3-powered digital infrastructure for global distributed renewable energy resources.

Key Points: 
  • OKX Wallet is thrilled to announce its integration with Arkreen , a revolutionary Web3-powered digital infrastructure for global distributed renewable energy resources.
  • This strategic partnership will enable eligible OKX Wallet users to access Arkreen through the OKX Wallet web extension.
  • This collaboration aligns perfectly with OKX Wallet's commitment to providing its users with innovative solutions that enhance their Web3 experience.
  • OKX Wallet users can now access Arkreen by downloading the OKX Wallet web extension available on Chrome and Firefox, creating or adding an existing OKX Wallet, and connecting it to Arkreen via the web extension.

Power Life By Tony Horton Launches Peak MCT & Collagen, an Innovative Vegan Supplement for Healthy Skin, Nimble Joints, and Strong Muscles

Retrieved on: 
Thursday, March 28, 2024
MCT, Dicarboxylic acid, Absorption, Joint, Biotin, Ligament, Skin, Water, Peak, LOS, Nail, Dietary supplement

LOS ANGELES, March 28, 2024 /PRNewswire/ -- Power Life™ by Tony Horton announces the launch of their newest product, Peak MCT & Collagen. Created by fitness legend Tony Horton, this dietary supplement is crafted with plant-based collagen, biotin, and MCT powder to support strong muscles and bones, limber joints, healthy hair, skin, and nails.†*

Key Points: 
  • A Potent Vegan Blend of Plant-Based Collagen, Biotin, and MCT Powder to Support Your Fitness and Weight Management Goals
    LOS ANGELES, March 28, 2024 /PRNewswire/ -- Power Life ™ by Tony Horton announces the launch of their newest product, Peak MCT & Collagen .
  • Created by fitness legend Tony Horton, this dietary supplement is crafted with plant-based collagen, biotin, and MCT powder to support strong muscles and bones, limber joints, healthy hair, skin, and nails.†*
    Power Life Peak MCT & Collagen is a potent dietary supplement crafted with plant-based biotin, MCT, prebiotic fiber, and vegan collagen amino acids.
  • The supplement's unique "rebuilding" formula actively stimulates your body to generate its own collagen, benefiting joints, bones, muscles, hair, skin, and nails.
  • Crafted exclusively from 100% plant-based ingredients, Power Life Peak MCT & Collagen is ideal for individuals seeking to enhance fitness and overall health.†*
    Simple to incorporate into your routine, just mix one scoop of Peak MCT & Collagen with 6-10oz.

Sunrider Unveils Skincare Breakthrough with Its Bio Cellulose Mask

Retrieved on: 
Wednesday, March 27, 2024
Absorption, Face, Hyaluronic acid, Pure, Nicotinamide, John Foster Dulles, Rejuvenation, Ibos, Cellulose, PCA, Dry, Sunrider, Skin, Fruit, Cosmetics

Crafted with advanced bio cellulose technology, the Kandesn® Pure Bio Cellulose Mask offers unparalleled hydration and rejuvenation for the skin.

Key Points: 
  • Crafted with advanced bio cellulose technology, the Kandesn® Pure Bio Cellulose Mask offers unparalleled hydration and rejuvenation for the skin.
  • "We are thrilled to introduce our new bio cellulose mask to our Independent Business Owners (IBOs) and customers," said Sunny Beutler, Sunrider CEO.
  • The Kandesn® Pure Bio Cellulose Mask is meant to complement and fit seamlessly into Sunrider's 4-step Kandesn® Pure skincare system, a vegan, botanically based skincare line designed to nourish, cleanse, and balance the skin.
  • The Kandesn® Pure Bio Cellulose Mask is available for purchase through Sunrider's network of IBOs and the company's website.

FERROFECT® Helps Address Anemia

Retrieved on: 
Wednesday, March 27, 2024
Pregnancy, Health, Absorption, Adenosine triphosphate, DNA replication, Cell, Zinc, DNA, Copper, Pharmacist, Quality of life, Woman, Supplement, Oxygen, ATP, WHO, Anemia, Iron, Digestion, Dietary supplement

FORT LAUDERDALE, Fla., March 27, 2024 /PRNewswire/ -- The body uses iron for many functions. Most of this iron is obtained through an individual's diet. However, when there is a chronic shortage of iron or the body struggles to synthesize it, it can be a problem. This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron). Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.

Key Points: 
  • This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron).
  • Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.
  • In addition, FERROFECT® helps with the production of adenosine triphosphate (ATP).
  • FERROFECT® even helps with DNA replication , a critical function required for cells to split and grow.

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Retrieved on: 
Monday, March 25, 2024
Transfer, AMS, Mass spectrometry, Absorption, Metabolism, Research, Patient, Biomarker, Medicine, TNO, Pharmaceutical industry

LEIDEN, Netherlands, March 25, 2024 /PRNewswire/ -- Ten years of development at TNO, the largest independent research and technology organisation in the Netherlands and one of the largest in the EU, has yielded a track record and acceptance by regulators of the accelerated biomedical mass spectrometry (AMS) technology. TNO aims to boost the technology's market impact by both developing the technology further and launching Peregrion. The purpose of this spin-off company is to aid pharmaceutical companies in accelerating their own early clinical development programmes. Using Accelerated biomedical Mass Spectrometry (AMS) for microtracer studies optimises and de-risks the development of candidate drugs. Peregrion is the 41st spin-off since the start of TNO Tech Transfer.

Key Points: 
  • TNO aims to boost the technology's market impact by both developing the technology further and launching Peregrion.
  • The purpose of this spin-off company is to aid pharmaceutical companies in accelerating their own early clinical development programmes.
  • Currently, a large number of top-20 pharmaceutical companies are using TNO's AMS technology to advance their medicine development programmes.
  • TNO is currently working on applying this technology for biomarkers and efficacy research in early clinical development.

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Retrieved on: 
Monday, March 25, 2024
Transfer, AMS, Mass spectrometry, Absorption, Metabolism, Research, Patient, Biomarker, Medicine, TNO, Pharmaceutical industry

LEIDEN, Netherlands, March 25, 2024 /PRNewswire/ -- Ten years of development at TNO, the largest independent research and technology organisation in the Netherlands and one of the largest in the EU, has yielded a track record and acceptance by regulators of the accelerated biomedical mass spectrometry (AMS) technology. TNO aims to boost the technology's market impact by both developing the technology further and launching Peregrion. The purpose of this spin-off company is to aid pharmaceutical companies in accelerating their own early clinical development programmes. Using Accelerated biomedical Mass Spectrometry (AMS) for microtracer studies optimises and de-risks the development of candidate drugs. Peregrion is the 41st spin-off since the start of TNO Tech Transfer.

Key Points: 
  • TNO aims to boost the technology's market impact by both developing the technology further and launching Peregrion.
  • The purpose of this spin-off company is to aid pharmaceutical companies in accelerating their own early clinical development programmes.
  • Currently, a large number of top-20 pharmaceutical companies are using TNO's AMS technology to advance their medicine development programmes.
  • TNO is currently working on applying this technology for biomarkers and efficacy research in early clinical development.